Microbiota Transplantation in Solid Organ Transplantation

Abroad (travel likely)Recruiting

Conditions

Solid Organ Transplant Complications

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Contact: Study coordinator (Faming Zhang, PhD) · fzhang@njmu.edu.cn · 025-25-58509883

Study leads

Faming Zhang, PhD
Principal Investigator
The Second Hospital of Nanjing Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) · Solid Organ Transplant Complications · Lymphoproliferative Disorders

Abroad (travel likely)RecruitingPHASE3

Duarte, United States · La Jolla, United States

Phase I Trial on the Safety of Delayed Infusion of a Naïve T Cell-Depleted Hematopoietic Graft With Memory T Cells in Solid Organ Transplant Recipients

Solid Organ Transplant Complications · Solid Organ Transplant Recipients · Solid Organ Transplant Rejection

Abroad (travel likely)RecruitingPHASE1

Madrid, Spain